Cargando…
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
Irinotecan-based regimens are used worldwide for the treatment of several recurrent or advanced gastrointestinal malignancies. In this paper we describe the cases of four patients treated in our institution who developed acute dysarthria while receiving intravenous infusion of irinotecan. In all our...
Autores principales: | De Lisa, Mariagrazia, Ballatore, Zelmira, Marcantognini, Giulia, Pierantoni, Chiara, Antognoli, Stefania, Pistelli, Mirco, Pagliacci, Alessandra, Berardi, Rossana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359989/ https://www.ncbi.nlm.nih.gov/pubmed/32700070 http://dx.doi.org/10.1007/s40487-019-00106-z |
Ejemplares similares
-
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
por: Pistelli, Mirco, et al.
Publicado: (2014) -
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
por: Pistelli, Mirco, et al.
Publicado: (2015) -
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2020) -
Irinotecan-Induced Dysarthria
por: Dressel, Albertine J., et al.
Publicado: (2012) -
Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013)